Peptide reverses cardiac fibrosis in a preclinical mannequin of congestive coronary heart failure
Cardiac fibrosis, an irregular thickening of the guts wall resulting in congestive coronary heart failure, was not solely halted but in addition reversed by a caveolin-1 surrogate peptide (CSD) in a preclinical mannequin, report researchers on the Medical College of South Carolina (MUSC) in an article revealed on-line on January 23, 2017 by Laboratory Investigation . CSD was in a position to lower the fibrotic ventricular wall thickness and enhance coronary heart perform, all with apparently no toxicity and minimal off-target results. The MUSC analysis crew included pulmonary fibrosis investigators Stanley Hoffman, Ph.D., and Elena V. Tourkina, Ph.D., who had beforehand proven caveolin-1's anti-fibrotic properties within the pores and skin and lung. For this venture, they joined forces with MUSC congestive coronary heart failure researchers within the laboratory of Dhandapani Kuppuswamy, Ph.D., to point out that caveolin-1's anti-fibrotic properties in pores and skin ...